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Unusual survival of an adult with pleuropulmonary blastoma
and neurofibromatosis
Noah B. Zuker, MD,a Charles A. Dietl, MD,b Sherry Kenna, RN,b Edgar G. Fischer, MD, PhD,c and David Gardner, MD,c
Albuquerque, New Mexico
A19-year-old white man, with neurofibromatosis type I,optic glioma, and history of blebectomy for sponta-neous left pneumothorax at age 17 years, presented tothe University of New Mexico Health Sciences Center
with chronic pain in the left side of his chest.
Clinical Summary
Chest radiography showed a solid mass encased within a large cystic
structure, suspicious for aspergilloma of the left lung. A chest
computed tomographic scan revealed a huge multiseptated cys-
tic structure involving the entire major fissure of the left lung,
containing a multilobulated soft tissue mass (Figure 1), and
measuring approximately 10  20 cm. The mass and cysts were
completely excised through a left thoracotomy. The specimen
weighed 85 g in aggregate and consisted of thin-walled cysts,
imparting a botryoid (ie, grape-like) appearance, with minor
solid components (Figure 2, A ). Microscopically, small imma-
ture tumor cells with ovoid to spindle-shaped nuclei were set in
a myxoid stroma. Cellularity was highest in the so-called cam-
bium layer just beneath the attenuated cyst lining (Figure 2, B).
Tumor cells were positive for desmin and other muscle markers
by immunohistochemistry. A diagnosis of pleuropulmonary
blastoma (PPB) type II was made. The patient’s postoperative
course was uneventful. Retrospective pathologic examination
of the blebectomy specimen obtained 2 years earlier revealed
subtle histologic features suggestive of PPB type I. The patient
received a multidrug regimen of 11 cycles of chemotherapy,
consisting of vincristine, actinomycin, and cyclophosphamide
during the first phase, and doxorubicin (Adriamycin; Bedford
Laboratories, Bedford, Ohio), cisplatin, and doxorubicin during
the second phase. Follow-up computed tomography scans of the
chest, abdomen, and pelvis revealed no evidence of recurrence
or metastasis at 24 months. The patient is currently asymptom-
atic with good weight gain and normal physical strength.
Discussion
This case report demonstrates the cardinal clinical and patho-
logic features of PPB, a highly aggressive childhood malig-
nancy, in an adult. These tumors present almost exclusively in
the first decade of life.1 To our knowledge, 4 adult patients have
been reported in the literature, with only 1 survivor at 29
months, after radiation therapy of a nonresectable PPB.2 It is
now recognized that 25% of PPB cases occur in a familial
setting with other tumors of childhood, such as cystic
nephroma, rhabdomyosarcoma, and synovial sarcoma.3 There
are no reports in the literature of any case of PPB associated
with neurofibromatosis. Clinical presentation of these rare tu-
mors may vary from ruptured lung blebs, as in our patient, or
space-occupying masses resembling a mediastinal teratoma4 to
more subtle manifestations of chest pathology or systemic dis-
ease. The clinical and radiographic differential diagnosis in-
cludes fungal lesions, congenital cystic adenomatoid malforma-
tion, bronchogenic cyst, and postinfectious pneumatocele.
Three pathologic types of PPB have been described: Type I is
purely cystic and may present as a congenital lung cyst; type II is
a combined cystic and solid tumor; and type III is solid and can be
accompanied by hemorrhage and necrosis.2
The potential for malignant transformation of mesenchymal
elements is emphasized by our case. The tendency for PPB to
transform from type I to type II after resection or possibly during
ontogeny is also illustrated by case reports with close follow-up
and early aggressive surgical resection of lung cysts in children.5
Further study may determine the effectiveness of prophylactic
resection in the absence of symptomatic disease.
The prognosis of pediatric patients affected with PPB is poor.
The largest case series reported an 83% 5-year survival for type I
and a 42% 5-year survival for types II and III.1 Concomitant
From the Department of Surgery,a Division of Thoracic and Cardiovascular
Surgery; and Departments of Surgeryb and Pathology,c University of New
Mexico Health Sciences Center, Albuquerque, New Mexico.
Received for publication April 14, 2007; accepted for publication April 26,
2007.
Reprint requests: Charles A. Dietl, MD, Thoracic and Cardiovascular
Surgery, Department of Surgery (ACC-2), University of New Mexico
Health Sciences Center MSC 10 5610, Albuquerque, NM 87131-0001
(E-mail: CDietl@salud.unm.edu).
J Thorac Cardiovasc Surg 2007;134:541-2
0022-5223/$32.00
Copyright © 2007 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.04.032
Figure 1. Chest computed tomographic scan showing a huge
multiseptated and multilobulated mass involving the entire major
fissure of the left lung.
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analysis of gene expression will be useful in determining adjuvant
chemotherapeutic regimens for rare cancers with documented gene
expression patterns. The nexus of multidisciplinary approaches
will generate an optimal treatment strategy for this complex dis-
ease, as advocated by several studies.
Three conclusions can be drawn from this rare case: PPB
should be considered in the clinical and radiographic differential
diagnosis when fungal disease or a congenital malformation is
suspected, even when the patient is a young adult; PPB can be
associated with neurofibromatosis type I, which has not been
described before; and, PPB in young adults could have a less
aggressive clinical course, but more experience is necessary with
patients in this age group.
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Figure 2. A, Gross appearance of the resected tumor with thin-
walled cysts imparting a botryoid appearance. B, Intermediate-
power photomicrograph showing the ill-defined cambium layer
with increased cellularity beneath the cyst lining (magnification
40). CL, Cambium layer; T, tumor.
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